Rare diseases
Investigational molecules
Locations
A study to test how well empagliflozin works and how safe it is for children and teenagers with chronic kidney disease
BelgiumStudy of Rocatinlimab with Topical Treatments for Adults with Moderate to Severe Atopic Dermatitis
BelgiumLong-term study of dabrafenib and trametinib in children and adolescents with cancers that have V600 mutation
BelgiumStudy of datopotamab deruxtecan with or without durvalumab compared to standard treatment for patients with Stage I-III triple-negative breast cancer who have remaining cancer after initial therapy
BelgiumStudy of bemarituzumab treatment for patients with solid tumors that have high levels of FGFR2b protein
BelgiumStudy of zolbetuximab, pembrolizumab and chemotherapy in adults with HER2-negative, Claudin 18.
BelgiumStudy of BI 765423 given by intravenous infusion for patients with idiopathic pulmonary fibrosis with or without standard treatment
BelgiumStudy of vicadrostat and empagliflozin given together or separately in people with chronic kidney disease to test safety and effectiveness
BelgiumStudy of ABBV-CLS-628 to evaluate safety and effectiveness in adults with Autosomal Dominant Polycystic Kidney Disease
BelgiumStudy on the Safety and Effects of GSK4418959 and Dostarlimab for Adults with Colorectal Cancer with Mismatch Repair Deficiency or High Microsatellite Instability
BelgiumStudy comparing empasiprubart versus intravenous immunoglobulin for treating adults with multifocal motor neuropathy
BelgiumStudy on the Safety and Effectiveness of MK-1654 for Preventing Respiratory Syncytial Virus (RSV) in Healthy Pre-Term and Full-Term Infants
BelgiumTell us about your condition – we search every trial in Europe and connect you with the right site.
